Abstract
In this “decade of the brain” it is important to note that the U.S population is becoming older, and all the attendant age-related central neuronal alterations as well as correlative behavioral changes will be showing increases as well. By the year 2050 fully 30% of the total population will be over 65 years of age and there is a high probability that they will be exhibiting the most common behavioral alterations occurring in aging (i.e., decrements in motor and certain types of memory functions). Specifically, alterations in motor function may include decreases in balance, muscle strength and coordination, while memory deficits appear to occur primarily in secondary memory systems and are reflected in the retrieval of newly acquired information. Indeed, these characterizations have been supported by a great deal of research both in animals and humans. It should be evident that in cases of severe deficits in memory (e.g., Alzheimer’s Disease, AD) or motor function (Parkinson’s Disease, PD) during aging and in age-related diseases hospitalization and/or custodial care would be a likely outcome. This means that unless some means is found to reduce these decrements in neuronal function the health care costs will be staggering, and today’s costs will pale by comparison.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, J.D. and Odun7P, I., 1991, Oxygen free radicals and parkinson’s disease, Free Rad. Biol. and Med. 10: 161.
Ainsworth, E.J., Fry, J.M., Brennan, P.C., Steamer, S.P., Rust, J.H., and Williamson, F.C., 1976, Life shortening, neoplasia and systematic injuries in mice after single or fractionated doses of neutron or gamma radiation, in: “Biological and Environmental Effects of Low-Level Radiation” IAEC, Vienna, Austria
Axelrod, J., Burch, R.M., and Jelsema, C.L., 1988, Recepto mediated activation of phospholipase A2 via GTP-binding protein arachidonic acid and its metabolites as second messengers, TINS, 11: 117.
Bimbaumer, L, 1991, On the origins and present state of the art of G protein research, J. Recep. Res. 11: 577.
Blake, M.J., Appel, N.M., Joseph, J.A., Stagg, C.A., Anson, M., De Souza, E.B. & Roth, G.S. 1991, Muscarinic acetylcholine receptor subtype mRNA expression and ligand binding in the aged rat brain, Neurobiol. Aging 12: 193.
Burnett, D.M., Daniell, L.C., and Zahniser, N.R., 1990, Decreased efficacy of inositol 1,4,5-trisphosphate to elicit calcium mobilization from cerebrocortical microsomes of aged rats Molec. Pharm. 37: 566.
Carney, J.M., Starke-Reed, P.E., Oliver, C.N., Landum, R.W., Cheng, M.S., Wu, J.F., and Floyd, R.A. 1991, Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity and loss in temporal spatial member by chronic administration of the spin-trapping compound N-tent butyl-aphenylnitrone Proc. Natl. Acad. Sci. USA, 88: 3633.
Cadet, J.L., Lohr, J.B., and Jeste, D.V., 1986, Free radicals and tardive dyskinesia, TINS 9:107. Choi, D. W., 1987, Ionic dependence of glutamate neurotoxicity, J. Neurosci. 7: 369.
Dawson, V.L., Dawson, T.M., Filloux, F.M. and Wamsley, J.K., 1988, Evidence for dopamine D-2 receptors on cholinergie intemeurons in the rat caudate putamen, Life Sci. 42: 1933.
Divac, I., Markowitsch, H.J., and Pritzel, M., 1978, Behavioral and anatomic consequences of small intrastriatal injections of kainic acid in the rat, Brain Res. 151: 523.
Favit, A., Nicoletti, F., Scapagnini, U., and Canonico, P.L., 1991, Ubiquinone protects cerebellar granule cells against glutamate-induced cytotoxicity, Soc. for Neurosci. Abs. 17: 791.
Fields, J.Z., Reisine, T.D., and Yamamura, H.I., 1978 Loss of striatal dopaminergic receptors after intrastriatal kainic acid injection, Life Sci. 23: 569.
Fisher, S.K. Heacock, A.M., and B.W. Agranoff, B.W., 1992, Inositol lipids and signal transduction in the nervous system: an update, J. Neurochem. 58: 18.
Flynn, D.D., Weinstein, D.A., and Mash, D.C., 1991, Loss of high affinity agonist binding to M1 muscarinic receptors in Alzheimer’s disease: Implications for the failure of cholinergic replacement therapy, Ann. Neurol. 29: 256.
Girotti, A.W., 1992, Photosensitized oxidation of cholesterol in biological systems: reaction pathways, cytotoxic effects and defense mechanisms, J. Potochem. Photobio. 13: 105.
Grimes, J.D., Hassan, M.N., and Thakar, J., 1987 Antioxidant therapy in Parkinson’s disease, Can. J. Neurol. Sci. 14 (3 Supplement): 483.
Halliwell, B. and Gutteridge J.M.C. 1989, Free Radicals in Biology and Medicine, Clarendon Press, Oxford, England.
Harman, D., 1981, The aging process, PNAS USA 78: 7124.
Henry, J., and Roth, G.S. 1986, Modulation of rat striatal membrane fluidity: effects on age-related differences in dopamine receptor concentrations, Life Sci. 39: 1223.
Heron, D.S., Israeli, M., Hershkowitz, M., and Samuel, D., 1980 Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes, PNAS USA, 77: 7463.
Joseph J.A. and Roth, G.S., 1988, Upregulation of striatal dopamine receptors and improvement of motor performance in senescence, in: “Central Determinants of Age Related Declines in Motor Function”, Annals of the New York Academy of Sciences Volume 515“, J.A. Joseph ed., New York Academy of Sciences, New York, NY.
Joseph, J. A., Dalton, T.K. and Hunt, W.A., 1988a, Age-related decrements in the muscarinic enhancement of K*-evoked release of endogenous striatal dopamine: An indicator of altered cholinergicdopaminergic reciprocal inhibitory control in senescence, Brain Res. 454: 140.
Joseph, J.A., Dalton, T.K., Roth, G.S., and Hunt, W.A. 1988b. Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: a deficit at the ligand-muscarinic receptor interface? Brain Res. 454: 149.
Joseph, J. A. and Roth, G.S., 1991, Loss of agonist receptor efficacy in senescence: Possible decrements in second messenger function and calcium mobilization. in: “Challenges in Aging: The 1990 Sandoz Lectures in Gerontology” M. Bergener, M. Ermini, and H.B. Stahelin, eds., Academic Press, New York, NY.
Joseph, J.A., Kowatch, M.A., Maki, T., and Roth, G.S. 1991a, Selective cross activation /inhibition of second messenger systems and the reduction of age-related deficits in the muscarinic control of dopamine release from perifused rat striata, Brain Res. 537: 40.
Joseph, J.A., Yamagami, K., and Roth, G.S., 199lb, Loss of muscarinic responsiveness in senescence may be the result of decreased membrane fluidity, Soc. for Neurosci Abs. 17: 53.
Joseph, J.A., Gupta, M., Han, Z., and Roth, G.S., 1991c, The deleterious effects of aging and kainic acid may be selective for the same striatal neuronal population and may share a common mechanism, Aging, 3: 361.
Joseph, J.A., Hunt, W.A., Rabin, B.M. and Dalton, T.K. 1992, Possible “accelerated striatal aging” induced by 56Fe heavy particle irradiation: Implications for manned space flights, Radiation Res. 130: 88.
Joseph, J.A., Hunt, W.A., Rabin, B.M. and Dalton, T.K., 1993, Deficits in the sensitivity of striatal muscarinic receptors induced by ‘Fe heavy particle irradiation: Further “age-radiation parallels,” Radiation Res. 135: 257.
Joseph, J. A., Villalobos-Molina, R., Rabin, B., Dalton, T., Harris, A., and Kandasamy, S., Reductions of 9Fe heavy particle irradiation-induced deficits in striatal muscarinic receptor sensitivity by selective cross activation/inhibition of second messenger systems, Rad. Res.,in press.
Lafon-Cazal, M., Pietre S., Culasi, M., and Bockaert J., 1993, NMDA-dependent superoxide production and neurotoxicity, Nature 364: 535.
Lyons, W.E., Puttfarcken, P.S., and Coyle, J.T., 1991, Protection against kainic acid toxicity with lipophilic antioxidants in cerebellar granule cell cultures, Soc. for Neurosci. Abs. 17: 785.
Mesco, E.R. Joseph, J.A., Blake, M.J., and Roth, G.S., 1991, Loss of D2 receptors during aging is partially due to decreased levels of mRNA, Brain Res. 545: 355.
Mesco, E.R., Joseph, J.A., and Roth, G.S., 1992, Selective susceptibility of cultured striatal neurons to kainic acid, J. Neurosci Res. 31: 341.
Mesco, E.R., Carlson, S.G., Joseph, J.A., and Roth, G.S., 1993, Synthetic rate of D2-dopamine receptor mRNA is selectively reduced during aging, Mol. Brain Res. 17: 160.
Missiaen, L. Taylor, C.W., and Berridge, M.J., 1991, Spontaneous calcium release from inositol trisphosphate-sensitive calcium stores, Nature 352: (6332): 242.
Morgan, D.G., 1987, The dopamine and serotonin systems during aging in human and rodent brain. A brief review., Prog Neuropsychopharm. Biol. Psych. 11: 153.
Murphy, T.H., Schnaar, R.L., and Coyle, J.T., 1990, Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 3: 1624.
Scatton, B., 1982, Further evidence for the involvement of D2 but not DI dopamine receptors in dopaminergic control of striatal cholinergic transmission, Life Sci. 31: 2882.
Schroeder, F., 1984 Role of membrane lipid asymmetry in aging, Neurobiol. Aging 5: 323.
Shinitzky, M. Heron, D.S., and Samuel, D., 1983, Restoration of membrane fluidity and serotonin receptors in aged mouse brain. in: “Aging of the Brain” Vol. 22“, D. Samuel, S., Algeri, S. Gershon, V.E. Grimm, and G. Tofano eds., Raven Press, New York.
Smith, C.J., Perry, E.K., Perry, R.H., Fairbaim, A.F., and N.J.M Birdsall, A.F., 1987, Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain a preliminary study in Alzheimer’s disease, Neurosci. Let. 82: 227.
Stark, G., 1991, The effect of ionizing radiation on lipid membranes, Biochim. Biophys. Acta 1071: 103.
Stoof, J.C., De Boer, T., Smina, P., and Mulder, A.H., 1982, Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gammaaminobutryic acid, glutamate or serotonin, Eur. J. Pharmacol. 84: 211.
Upton, A.C., 1959, Ionizing radiation and aging. Gerontologia, 4: 162.
Vedova, F.D., Fumagalli, F., Sachetti, G., Racagni, G., and Brunello, N, 1992, Age-related variations in relative abundance of alternative spliced receptor mRNA’s in brain areas of two rat strains, Mol. Brain Res. 12: 357.
Villalobos-Molina, R., Joseph, J.A., Rabin, B., Kandasamy, S., Dalton, T.K., and Roth, G.S., ~Fe irradiation diminishes muscarinic but not alpha-1 adrenergic stimulated low Km GTPase in rat brain, Radial. Res.,submitted.
Warpman, U., Alafuzoff, I., and Nordberg, A., 1993, Couupling of muscarinic receptors to GTP proteins in postmortem human brain-alterations in Alzheimer’s disease, Neurosci. Let. 150: 39.
Yamagami, K., Joseph, J.A., and Roth, G.S., 1991, Decreased concentrations of striatal muscarinic receptors and age-related decrement in muscarinic enhancement of K’-evoked release of endogenous dopamine, Neurobiol. Aging 13: 51.
Yamagami, K., Joseph, J.A., and Roth, G.S., 1992, Decrement of muscarinic receptor-stimulated low Km GTPase activity in striata and hippocampus from aged rat, Brain Res. 576: 327.
Zhu, X-Z, and Luo, L-G., 1992, Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices, J. Neurochem. 59: 932.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Joseph, J.A., Roth, G.S. (1995). Oxidative Stress and the Loss of Receptor Sensitivity in Aging. In: Hanin, I., Yoshida, M., Fisher, A. (eds) Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 44. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9145-7_47
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9145-7_47
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9147-1
Online ISBN: 978-1-4757-9145-7
eBook Packages: Springer Book Archive